Showing results (121-130 of 621) with videos related to
Sort By:
Pageof 63
Annals of the Rheumatic Diseases|April 12, 2006
Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature reviewJ Avouac, L Gossec, M DougadosLa Revue Du Praticien|January 15, 1994
[Lipid microcrystals and other rare crystals in the joints]D Tourlière, C L BenhamouClinical and Experimental Rheumatology|November 18, 2009
Glucocorticoid sparing effect of tumour necrosis factor alpha inhibitors in rheumatoid arthritis in real life practiceR Seror, M Dougados, L GossecRMD Open|February 13, 2016
Factors associated with a bad functional prognosis in early inflammatory back pain: results from the DESIR cohortC Lukas, M Dougados, B CombeBritish Journal of Rheumatology|January 1, 1997
Prolonged effects of 3 week therapy in a spa resort on lumbar spine, knee and hip osteoarthritis: follow-up after 6 months. A randomized controlled trialM Nguyen, M Revel, M DougadosAnnals of the Rheumatic Diseases|October 27, 2007
Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature reviewN Zeboulon, M Dougados, L GossecInternational Journal of Clinical Practice|January 4, 2003
A hyaluronan preparation (500-730 kDa) in the treatment of osteoarthritis: a review of clinical trials with HyalganE Maheu, X Ayral, M DougadosClinical and Experimental Rheumatology|December 15, 2007
Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case reportS Guignard, G Dien, M DougadosAnnals of the Rheumatic Diseases|January 22, 2008
Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trialsC Salliot, M Dougados, L GossecLa Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|December 12, 1983
[Double-blind comparative study of slow-release ketoprofen and a placebo in chronic inflammatory rheumatism]J M Harrewyn, B AmorPageof 63